The Human Genome Project began more than 30 years ago, lasted more than 13 years, and cost 2.7 billion US dollars to complete. Most of the high prices come from research inspired by genomics and the medical revolution. Today, the sequencing technology itself has also undergone revolutionary changes. The entire human genome can be sequenced simultaneously in one day.
NGS technology has been around since the early 2000s and has reached the point where it can quickly generate millions of data points at the same time cost-effectively and efficiently. However, the main applications of NGS are mainly limited to research, applied science and public health, and laboratories to characterize outbreaks of foodborne pathogens.
With the Covid-19 pandemic, people are increasingly aware of the power and utility of NGS as the driving force behind genomic epidemiology and a key tool to counter global biological threats. As we seek to address current challenges and develop plans to prevent and respond to future epidemics, genomic advances made as part of raising awareness will help us.
Whole Genome Sequencing One A key role in the pandemic.
The ability to capture key information about the genome is a way to help identify SARS-CoV-2 as the causative agent of Covid-19. Therefore, researchers can study and characterize the pathogen’s molecules, not only to determine the presence of SARS-CoV-2, but also to assess how the virus affects human health in a specific environment, and to track the spread and mutation of its genetic sequence as a virus. This is especially important for rapidly mutating and spreading viruses (such as SARS-CoV-2). The transmission rate of the Delta variant that caused all infections in the United States was twice that of the virus version that appeared in Wuhan, China. Now that we have Omicron, it turns out to be more contagious than Delta.
The importance of genome sequencing in the battle against Covid-19 does not stop at disease identification; NGS technology allows rapid sequencing of millions of RNA base pairs, providing accurate genome sequences, which leads to nucleic acid diagnostic tests and mRNA Vaccine development. As the virus spreads and mutates, WGS remains the method of choice for tracking outbreaks, spreading, and monitoring mutations.
Continuous sequencing is essential for better virus management.
The Covid-19 pandemic has focused on the urgent and urgent need for next-generation sequencing tools that can generate valuable data that can not only identify emerging variants, but also understand the function and epidemiology of variant-specific mutations as a result of. SARS-CoV-2 is nothing if not unpredictable. The continuous emergence and dissemination of new variants has strengthened the critical role of genome sequencing in strengthening the surveillance of Covid-19. In order to keep up with the evolving virus, we need to adopt fast and reliable genome monitoring tools that are commensurate with the task.
Thanks to advances in cloud, connectivity and high-throughput, next-generation sequencing, scientists around the world can observe the evolution of this virus in real time, because mutations will weaken the virus, or in the case of Delta, enhance the virus and speed up its spread.
With the impact of Covid-19, a strong interest in the widespread adoption of NGS technology is gaining momentum, including in clinical laboratories. The best platforms will use turnkey automation, requiring almost no human intervention. The results will be available in hours instead of days. The fast workflow solution will be end-to-end. In the case of limited global supply, you can choose to purchase kits and consumables.
The future of sequencing affects the future of the pandemic
After a brutal summer with a peak of 2,000 deaths every day, we had a brief calm before Omicron appeared. It seems to avoid vaccines, but may cause mild illness compared to Delta.
Even if Covid-19 has passed, we don’t know when, but the reality is that this epidemic will not be the last. This is especially true when we enter the flu season and expect that many hidden pathogens will reappear. Therefore, we must make appropriate investments in sequencing so that laboratories, clinicians, and global health officials can better track, understand, and mitigate current and future pathogens.
Continuous monitoring is essential for continuous understanding of SARS-CoV-2 and its mutations. Any change in the number of Covid-19 cases will only further validate the need to continue testing so that the world can keep up with the pandemic and future variants.
Covid-19 will not disappear anytime soon. Scientists predict that it will continue to spread in the next few years. Although vaccines can transform Covid-19 from a global threat to a controllable disease (such as flu or the common cold), it is vital to stay ahead of the curve by continuing to monitor and sequence to perform the most critical epidemiological analysis in the most timely manner possible.
Photo: santima.studio, Getty Images
